These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20667732)

  • 41. Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics.
    Garcia-Barrantes PM; Cho HP; Niswender CM; Byers FW; Locuson CW; Blobaum AL; Xiang Z; Rook JM; Conn PJ; Lindsley CW
    J Med Chem; 2015 Oct; 58(20):7959-71. PubMed ID: 26426481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring the active conformation of cyclohexane carboxylate positive allosteric modulators of the type 4 metabotropic glutamate receptor.
    Rovira X; Harrak Y; Trapero A; González-Bulnes P; Malhaire F; Pin JP; Goudet C; Giraldo J; Llebaria A
    ChemMedChem; 2014 Dec; 9(12):2685-98. PubMed ID: 25196639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.
    Xiong H; Brugel TA; Balestra M; Brown DG; Brush KA; Hightower C; Hinkley L; Hoesch V; Kang J; Koether GM; McCauley JP; McLaren FM; Panko LM; Simpson TR; Smith RW; Woods JM; Brockel B; Chhajlani V; Gadient RA; Spear N; Sygowski LA; Zhang M; Arora J; Breysse N; Wilson JM; Isaac M; Slassi A; King MM
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7381-4. PubMed ID: 21067920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The computational modeling of allosteric modulation of metabotropic glutamate receptors.
    Pérez-Benito L; Llinas Del Torrent C; Pardo L; Tresadern G
    Adv Pharmacol; 2020; 88():1-33. PubMed ID: 32416864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu
    Bollinger SR; Engers DW; Panarese JD; West M; Engers JL; Loch MT; Rodriguez AL; Blobaum AL; Jones CK; Thompson Gray A; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    J Med Chem; 2019 Jan; 62(1):342-358. PubMed ID: 30247901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovery, characterization, and antiparkinsonian effect of novel positive allosteric modulators of metabotropic glutamate receptor 4.
    Niswender CM; Johnson KA; Weaver CD; Jones CK; Xiang Z; Luo Q; Rodriguez AL; Marlo JE; de Paulis T; Thompson AD; Days EL; Nalywajko T; Austin CA; Williams MB; Ayala JE; Williams R; Lindsley CW; Conn PJ
    Mol Pharmacol; 2008 Nov; 74(5):1345-58. PubMed ID: 18664603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel sulfamoyl benzamides as selective CB(2) agonists with improved in vitro metabolic stability.
    Sellitto I; Le Bourdonnec B; Worm K; Goodman A; Savolainen MA; Chu GH; Ajello CW; Saeui CT; Leister LK; Cassel JA; Dehaven RN; Labuda CJ; Koblish M; Little PJ; Brogdon BL; Smith SA; Dolle RE
    Bioorg Med Chem Lett; 2010 Jan; 20(1):387-91. PubMed ID: 19919895
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orally active metabotropic glutamate subtype 2 receptor positive allosteric modulators: structure-activity relationships and assessment in a rat model of nicotine dependence.
    Sidique S; Dhanya RP; Sheffler DJ; Nickols HH; Yang L; Dahl R; Mangravita-Novo A; Smith LH; D'Souza MS; Semenova S; Conn PJ; Markou A; Cosford ND
    J Med Chem; 2012 Nov; 55(22):9434-45. PubMed ID: 23009245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and SAR of novel, non-MPEP chemotype mGluR5 NAMs identified by functional HTS.
    Zhou Y; Rodriguez AL; Williams R; Weaver CD; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6502-6. PubMed ID: 19875287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of potent and selective beta(3) adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres.
    Uehling DE; Donaldson KH; Deaton DN; Hyman CE; Sugg EE; Barrett DG; Hughes RG; Reitter B; Adkison KK; Lancaster ME; Lee F; Hart R; Paulik MA; Sherman BW; True T; Cowan C
    J Med Chem; 2002 Jan; 45(3):567-83. PubMed ID: 11806709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu
    Engers DW; Bollinger SR; Engers JL; Panarese JD; Breiner MM; Gregro A; Blobaum AL; Bronson JJ; Wu YJ; Macor JE; Rodriguez AL; Zamorano R; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    Bioorg Med Chem Lett; 2018 Aug; 28(15):2641-2646. PubMed ID: 29958762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel arylsulfoanilide-oxindole hybrid as an anticancer agent that inhibits translation initiation.
    Natarajan A; Guo Y; Harbinski F; Fan YH; Chen H; Luus L; Diercks J; Aktas H; Chorev M; Halperin JA
    J Med Chem; 2004 Oct; 47(21):4979-82. PubMed ID: 15456240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a highly potent, novel M5 positive allosteric modulator (PAM) demonstrating CNS exposure: 1-((1H-indazol-5-yl)sulfoneyl)-N-ethyl-N-(2-(trifluoromethyl)benzyl)piperidine-4-carboxamide (ML380).
    Gentry PR; Kokubo M; Bridges TM; Noetzel MJ; Cho HP; Lamsal A; Smith E; Chase P; Hodder PS; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Wood MR
    J Med Chem; 2014 Sep; 57(18):7804-10. PubMed ID: 25147929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.
    Williams R; Manka JT; Rodriguez AL; Vinson PN; Niswender CM; Weaver CD; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1350-3. PubMed ID: 21315585
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tricyclic thiazolopyrazole derivatives as metabotropic glutamate receptor 4 positive allosteric modulators.
    Hong SP; Liu KG; Ma G; Sabio M; Uberti MA; Bacolod MD; Peterson J; Zou ZZ; Robichaud AJ; Doller D
    J Med Chem; 2011 Jul; 54(14):5070-81. PubMed ID: 21688779
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs.
    Garcia-Barrantes PM; Cho HP; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1869-72. PubMed ID: 26988302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization.
    Duplantier AJ; Efremov I; Candler J; Doran AC; Ganong AH; Haas JA; Hanks AN; Kraus KG; Lazzaro JT; Lu J; Maklad N; McCarthy SA; O'Sullivan TJ; Rogers BN; Siuciak JA; Spracklin DK; Zhang L
    Bioorg Med Chem Lett; 2009 May; 19(9):2524-9. PubMed ID: 19328692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structure-Activity Relationships of Pan-Gα
    Berizzi AE; Bender AM; Lindsley CW; Conn PJ; Sexton PM; Langmead CJ; Christopoulos A
    ACS Chem Neurosci; 2018 Jul; 9(7):1818-1828. PubMed ID: 29683647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy switching SAR of mGluR5 allosteric modulators: highly potent positive and negative modulators from one chemotype.
    Sams AG; Mikkelsen GK; Brodbeck RM; Pu X; Ritzén A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3407-10. PubMed ID: 21531137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.